Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

Our medical research system, AMIE, is the first patient-facing conversational diagnostic tool of its kind to be studied prospectively in a real-world clinical setting. In a study, published today in The Lancet, we found that when patients chatted with AMIE before an in-person appointment, the interaction built their confidence... show more

Google

31,896,050 subscribers

135,927 views • 3 days ago •via X (Twitter)

Health & Wellness Science & Technology

Anya Rossi• Live Now

Private livecam show

8 Comments

Google3 days ago

Conducted in partnership with @BIDMC_Medicine, the study demonstrates technology’s potential to strengthen the relationship between doctors and patients. Learn more ↓

Julian C3 days ago

@TheLancet So, does AMIE actually help docs catch stuff they might've missed, or is it more about efficiency?

Devin Soto3 days ago

@TheLancet So physicians are next on the chopping block from AI?

why3 days ago

@TheLancet Prospective testing with real patients is a meaningful step beyond benchmark scores. Curious how the findings compare with the in-person visits.

John Petrov3 days ago

@TheLancet The real test is whether it catches the 30 people who have no idea what’s wrong with them. If it just confirms what they already suspect, it’s just a fancy chatbot.

张思考者3 days ago

Transitioning conversational diagnostic models from synthetic benchmarks to prospective clinical validation in The Lancet marks a vital maturation of applied intelligence. Grounding frontier reasoning systems in real-world healthcare workflows illustrates how specialized computational architecture can structurally expand clinical capacity and alleviate persistent global diagnostic deficits.

surreal intelligence3 days ago

@TheLancet Remembering what you meant to ask on the way home is a familiar frustration. Helping people arrive ready to explain what’s worrying them could make those precious minutes with a doctor count for more.

Master Thought3 days ago

@TheLancet This is a fascinating step for AI in healthcare. 🤖🩺 Helping patients organize their concerns while giving physicians more time for meaningful conversations could make clinical care more efficient and patient-centered.

Related Videos

Today The Lancet published our AMIE study with BIDMC Department of Medicine, the first prospective study of patient-facing conversational diagnostics in a real clinic. AMIE is a research system people can chat with before doctors appointments. Testing AMIE outside the lab with real urgent care patients showed how technology can help gather medical histories safely. Clinicians reported that the summaries helped them prepare for visits in 75% of cases and influenced their approach to care in more than half. AMIE’s differential diagnoses also matched the doctors’ final diagnoses 90% of the time giving clinicians more time to focus on patient care. It’s Google’s first-ever paper in The Lancet’s main journal!

Today The Lancet published our AMIE study with BIDMC Department of Medicine, the first prospective study of patient-facing conversational diagnostics in a real clinic. AMIE is a research system people can chat with before doctors appointments. Testing AMIE outside the lab with real urgent care patients showed how technology can help gather medical histories safely. Clinicians reported that the summaries helped them prepare for visits in 75% of cases and influenced their approach to care in more than half. AMIE’s differential diagnoses also matched the doctors’ final diagnoses 90% of the time giving clinicians more time to focus on patient care. It’s Google’s first-ever paper in The Lancet’s main journal!

Sundar Pichai

330,521 views • 3 days ago

Today, we're announcing the next evolution of Sword Thrive: a fully revamped experience anchored by a new conversational care model, Vision AI, and a more powerful Phoenix. At the center of this evolution is a first-of-its-kind care model: a 3-way chat connecting the member, Phoenix, and their Doctor of Physical Therapy in a single interface, making continuous, 24/7 care possible for the first time, with the clinical oversight only a human specialist can provide. Vision AI, our proprietary technology trained on years of movement data, now delivers precise movement detection in real-world home environments - cluttered, noisy, and everything in between - and runs entirely through the Sword Health app on smartphones and tablets. Phoenix, our AI Care Specialist, is now more capable as well, providing deeper, personalized two-way conversational guidance and real-time form correction, adapting to each member as they move. From proactive care to continuous recovery, this is how healthcare should show up: with reliability, clinical memory, and real-time support that never drops the thread. Watch the video to see it in action:

Today, we're announcing the next evolution of Sword Thrive: a fully revamped experience anchored by a new conversational care model, Vision AI, and a more powerful Phoenix. At the center of this evolution is a first-of-its-kind care model: a 3-way chat connecting the member, Phoenix, and their Doctor of Physical Therapy in a single interface, making continuous, 24/7 care possible for the first time, with the clinical oversight only a human specialist can provide. Vision AI, our proprietary technology trained on years of movement data, now delivers precise movement detection in real-world home environments - cluttered, noisy, and everything in between - and runs entirely through the Sword Health app on smartphones and tablets. Phoenix, our AI Care Specialist, is now more capable as well, providing deeper, personalized two-way conversational guidance and real-time form correction, adapting to each member as they move. From proactive care to continuous recovery, this is how healthcare should show up: with reliability, clinical memory, and real-time support that never drops the thread. Watch the video to see it in action:

Sword

28,071 views • 7 months ago

Over 1 million clinical questions hit OpenEvidence every day. More than half the practicing physicians in the US rely on us at the point of care, mid-decision, with a patient in front of them. Downtime in that moment has real consequences. We partner with Baseten for our inference infrastructure to make sure answers are always there when physicians need them. They stopped by our office to talk about what that looks like under the hood.

Over 1 million clinical questions hit OpenEvidence every day. More than half the practicing physicians in the US rely on us at the point of care, mid-decision, with a patient in front of them. Downtime in that moment has real consequences. We partner with Baseten for our inference infrastructure to make sure answers are always there when physicians need them. They stopped by our office to talk about what that looks like under the hood.

OpenEvidence

107,233 views • 6 months ago

The Board of REACT19 regrets to inform our community of the sudden cancellation of this week’s meeting of the Advisory Committee on Immunization Practices (ACIP) at the CDC. The meeting was cancelled following a federal court ruling that blocked recent vaccine policy changes and invalidated the current ACIP advisory panel while legal challenges move forward. For many in our community, this meeting represented a long-awaited opportunity. After more than five years of waiting, patients and families had prepared impact statements in hopes that the urgent need for clinical recognition, research, and care for those suffering from serious post-vaccination conditions would finally be discussed. For those living with these conditions, this cancellation is deeply painful. It means more waiting, more uncertainty, and more time without the clinical guidance needed to help physicians recognize, diagnose, and treat patients who have been suffering for years. Our hearts are with every member of this community who had hoped their voice would finally be heard this week. However, even in this difficult moment, important progress continues. On March 18, REACT19 will still be part of a historic step forward at the CDC. A proposal for a new ICD-10 diagnostic code related to post-COVID-19 vaccination conditions will be presented, opening a public comment period and moving the medical system closer to formally recognizing these patients. Diagnostic codes are more than administrative tools. They are a critical foundation for clinical recognition, medical education, research, insurance coverage, and ultimately the development of treatments. Establishing an ICD-10 code would represent an important step toward building the clinical infrastructure needed to care for patients who have too often been left without answers. While the cancellation of the ACIP meeting is a heartbreaking setback for our community, the work to achieve medical recognition and appropriate care continues. If the U.S. Department of Health and Human Services prevails in its appeal, the ACIP process may resume. In the meantime, REACT19 remains committed to ensuring that the voices of patients are heard and that progress toward recognition, research, and care does not stop. To every patient and family who has shared their story and stood with us through years of uncertainty: we see you, we hear you, and we will continue advocating for the care and recognition you deserve. — Board of Directors REACT19

The Board of REACT19 regrets to inform our community of the sudden cancellation of this week’s meeting of the Advisory Committee on Immunization Practices (ACIP) at the CDC. The meeting was cancelled following a federal court ruling that blocked recent vaccine policy changes and invalidated the current ACIP advisory panel while legal challenges move forward. For many in our community, this meeting represented a long-awaited opportunity. After more than five years of waiting, patients and families had prepared impact statements in hopes that the urgent need for clinical recognition, research, and care for those suffering from serious post-vaccination conditions would finally be discussed. For those living with these conditions, this cancellation is deeply painful. It means more waiting, more uncertainty, and more time without the clinical guidance needed to help physicians recognize, diagnose, and treat patients who have been suffering for years. Our hearts are with every member of this community who had hoped their voice would finally be heard this week. However, even in this difficult moment, important progress continues. On March 18, REACT19 will still be part of a historic step forward at the CDC. A proposal for a new ICD-10 diagnostic code related to post-COVID-19 vaccination conditions will be presented, opening a public comment period and moving the medical system closer to formally recognizing these patients. Diagnostic codes are more than administrative tools. They are a critical foundation for clinical recognition, medical education, research, insurance coverage, and ultimately the development of treatments. Establishing an ICD-10 code would represent an important step toward building the clinical infrastructure needed to care for patients who have too often been left without answers. While the cancellation of the ACIP meeting is a heartbreaking setback for our community, the work to achieve medical recognition and appropriate care continues. If the U.S. Department of Health and Human Services prevails in its appeal, the ACIP process may resume. In the meantime, REACT19 remains committed to ensuring that the voices of patients are heard and that progress toward recognition, research, and care does not stop. To every patient and family who has shared their story and stood with us through years of uncertainty: we see you, we hear you, and we will continue advocating for the care and recognition you deserve. — Board of Directors REACT19

React19 - Official

33,505 views • 6 months ago

From sample collection to report delivery, our passionate and dedicated lab team provides the highest quality of care and precision for each and every patient we sequence. This steadfast commitment is essential to providing physicians with the data-driven insights needed to personalize their patients' care. Follow the journey below.

From sample collection to report delivery, our passionate and dedicated lab team provides the highest quality of care and precision for each and every patient we sequence. This steadfast commitment is essential to providing physicians with the data-driven insights needed to personalize their patients' care. Follow the journey below.

Tempus

13,199 views • 1 year ago

Why do people with Crohn's and Colitis flare? This is the fundamental question we set out to answer when we started the PREdiCCt study in 2016. On Tuesday, the first major results will be published in Gut Journal We wanted to look beyond just the clinical data. We focused on the environment: diet, lifestyle, exercise, sleep, and stress. By combining these factors with the microbiome and genetics, we aimed to understand the true drivers of disease activity over time. This has been a decade in the making. We recruited 2,629 patients across 49 adult and pediatric sites before the pandemic halted recruitment in March 2020. Since then, our team has been busy assimilating years of follow up data. Most participants have now been followed for over four years. In this video, I talk through the background and design of the study. It represents a massive collective effort from clinical trials units, statisticians, and project managers. Most importantly, it represents the dedication of the people living with IBD who gave their time to this research. Our goal is to provide the evidence needed to help patients stay in deep remission and to help clinical teams provide better, more personalized care. I look forward to sharing the findings with you this week. Institute of Genetics and Cancer The University of Edinburgh NHS Lothian Nathan Constantine-Cooke PREdiCCt Beatriz Gros @PlevrisN UK Research and Innovation

Why do people with Crohn's and Colitis flare? This is the fundamental question we set out to answer when we started the PREdiCCt study in 2016. On Tuesday, the first major results will be published in Gut Journal We wanted to look beyond just the clinical data. We focused on the environment: diet, lifestyle, exercise, sleep, and stress. By combining these factors with the microbiome and genetics, we aimed to understand the true drivers of disease activity over time. This has been a decade in the making. We recruited 2,629 patients across 49 adult and pediatric sites before the pandemic halted recruitment in March 2020. Since then, our team has been busy assimilating years of follow up data. Most participants have now been followed for over four years. In this video, I talk through the background and design of the study. It represents a massive collective effort from clinical trials units, statisticians, and project managers. Most importantly, it represents the dedication of the people living with IBD who gave their time to this research. Our goal is to provide the evidence needed to help patients stay in deep remission and to help clinical teams provide better, more personalized care. I look forward to sharing the findings with you this week. Institute of Genetics and Cancer The University of Edinburgh NHS Lothian Nathan Constantine-Cooke PREdiCCt Beatriz Gros @PlevrisN UK Research and Innovation

Charlie Lees

16,359 views • 8 months ago

A few days ago, we learned that the first patient in the U.S., to our knowledge, has been dosed with lidocaine for their breast cancer treatment. Just six weeks ago, we learned about the potential connection between lidocaine and improved breast cancer outcomes from a groundbreaking clinical trial of 1,600 patients conducted in India. That study showed a potential 30% reduction in five-year mortality for patients who received lidocaine injections into their tumors before surgery. Since then, we've engaged in discussions with specialists and researchers, and what we’ve discovered has been surprising —no one seemed to be using this approach, despite the data available. The other day, one of those conversations turned into action. A doctor we spoke to decided to inject a tumor with lidocaine before removing it, marking a critical first step toward translating global insights into real-world patient care. This moment excites us because it shows the power of accelerating drug repurposing insights into clinical practice. At Every Cure, this is exactly what drives us: identifying overlooked opportunities and ensuring they reach patients who need them most—quickly and efficiently. #medtwitter

A few days ago, we learned that the first patient in the U.S., to our knowledge, has been dosed with lidocaine for their breast cancer treatment. Just six weeks ago, we learned about the potential connection between lidocaine and improved breast cancer outcomes from a groundbreaking clinical trial of 1,600 patients conducted in India. That study showed a potential 30% reduction in five-year mortality for patients who received lidocaine injections into their tumors before surgery. Since then, we've engaged in discussions with specialists and researchers, and what we’ve discovered has been surprising —no one seemed to be using this approach, despite the data available. The other day, one of those conversations turned into action. A doctor we spoke to decided to inject a tumor with lidocaine before removing it, marking a critical first step toward translating global insights into real-world patient care. This moment excites us because it shows the power of accelerating drug repurposing insights into clinical practice. At Every Cure, this is exactly what drives us: identifying overlooked opportunities and ensuring they reach patients who need them most—quickly and efficiently. #medtwitter

David Fajgenbaum, MD

55,805 views • 1 year ago

2026: A patient reached out to me yesterday to let me know about a concerning interaction with a hospital system. The patient was scheduled for a therapeutic procedure, in advance of surgery. Arrangements were made and the patient paid their estimated portion of the cost. Then they received a call from the facility asking them whether they still had the same insurance. When the patient confirmed that nothing had changed, they received a warning from the facility that the estimate no longer applied and costs could go up…significantly. Why? Because the hospital system is renegotiating with the insurance company. Not because the clinical situation changed, not because the procedure became more complex…just because the patient is caught in the middle of a business negotiation without an advocate. So they called me. And I’m telling all of you. So we can help one another by insisting that patients come first. Always.

2026: A patient reached out to me yesterday to let me know about a concerning interaction with a hospital system. The patient was scheduled for a therapeutic procedure, in advance of surgery. Arrangements were made and the patient paid their estimated portion of the cost. Then they received a call from the facility asking them whether they still had the same insurance. When the patient confirmed that nothing had changed, they received a warning from the facility that the estimate no longer applied and costs could go up…significantly. Why? Because the hospital system is renegotiating with the insurance company. Not because the clinical situation changed, not because the procedure became more complex…just because the patient is caught in the middle of a business negotiation without an advocate. So they called me. And I’m telling all of you. So we can help one another by insisting that patients come first. Always.

Elisabeth Potter MD

55,057 views • 9 months ago

RFK Jr. just CALLED OUT Germany for prosecuting doctors and patients over COVID vaccine and masking exemptions. “More than a thousand German physicians and thousands of their patients now face prosecution and punishment for issuing exemptions from wearing masks or getting COVID-19 vaccines.” “When any government criminalizes doctors for advising their patients, it crosses a line that free societies have always treated as sacred.” “Germany is targeting physicians who put their patients first and punishing citizens for making their own medical choices.” “The German government is now violating the sacred patient-physician relationship.” “No democracy grounded in confidence and transparency should move in that direction.”

RFK Jr. just CALLED OUT Germany for prosecuting doctors and patients over COVID vaccine and masking exemptions. “More than a thousand German physicians and thousands of their patients now face prosecution and punishment for issuing exemptions from wearing masks or getting COVID-19 vaccines.” “When any government criminalizes doctors for advising their patients, it crosses a line that free societies have always treated as sacred.” “Germany is targeting physicians who put their patients first and punishing citizens for making their own medical choices.” “The German government is now violating the sacred patient-physician relationship.” “No democracy grounded in confidence and transparency should move in that direction.”

End Tribalism in Politics

11,658 views • 9 months ago

Jewish billionaire Michael Milken warns that the entire world will be forced to load their digital health records onto their phones and rely on an AI physician for medical care in the very near future. “It won’t be long before you have a medical teammate who has all your clinical information and all your medical information.” “These will be available to every single person on the planet someday.”

Jewish billionaire Michael Milken warns that the entire world will be forced to load their digital health records onto their phones and rely on an AI physician for medical care in the very near future. “It won’t be long before you have a medical teammate who has all your clinical information and all your medical information.” “These will be available to every single person on the planet someday.”

Shadow of Ezra

270,682 views • 5 months ago

#WATCH | Ahmedabad, Gujarat: Dr Sandip Sonara, Advanced Gynec laparoscopic Surgeon and Endometriosis Specialist says, "Recently I have published a research paper in which I have diagnosed a rare presentation of endometriosis. The patient was suffering from symptoms like endometriosis or I can say pain and infertility for 14 years… This patient was suffering from pain during menstruation, back pain and infertility. She consulted orthopaedic surgeons, gynaecologists and pain specialists. No one was able to diagnose the disease. When the patient came to me and my team, we thoroughly examined the patient… We operated on the patient and we removed the cyst located at the bottom of the uterus. We removed it and it proved to be a mesonephric cyst endometrioma. Regarding the rarity of this case, it was diagnosed in humans for the first time in the world. Before this case, it was diagnosed only in dogs, only three times in the world. We were the first to diagnose and treat this disease in humans, and we operated and treated the patient."

#WATCH | Ahmedabad, Gujarat: Dr Sandip Sonara, Advanced Gynec laparoscopic Surgeon and Endometriosis Specialist says, "Recently I have published a research paper in which I have diagnosed a rare presentation of endometriosis. The patient was suffering from symptoms like endometriosis or I can say pain and infertility for 14 years… This patient was suffering from pain during menstruation, back pain and infertility. She consulted orthopaedic surgeons, gynaecologists and pain specialists. No one was able to diagnose the disease. When the patient came to me and my team, we thoroughly examined the patient… We operated on the patient and we removed the cyst located at the bottom of the uterus. We removed it and it proved to be a mesonephric cyst endometrioma. Regarding the rarity of this case, it was diagnosed in humans for the first time in the world. Before this case, it was diagnosed only in dogs, only three times in the world. We were the first to diagnose and treat this disease in humans, and we operated and treated the patient."

ANI

10,724 views • 1 year ago

Today we're announcing Base Labs, a dedicated research organization focused on advancing open-source AI. We believe in a healthy, open frontier model ecosystem. To enable this, we are working on: - Blue-sky research on continual learning, the science of RL, and how models learn across their full lifecycle, with every experiment and recipe shared openly. - The BaseHub Data Foundry: the highest-quality open RL environments, training data, and real-world benchmarks, built for anyone to train and benchmark on. - Post-post training: taking open-source models and making them better, safer, and more aligned through continual post-training, built on our research, and deployed with our frontier safety stack so organizations can use open-source models with confidence. - Making models cheaper and more performant through our model performance research. This is a mission-driven research effort, not a commercial product. We believe the health of the open-source AI ecosystem matters and that the best way to advance it is to do science in the open. We’re hiring engineers, researchers, and research fellows to advance this mission.

Today we're announcing Base Labs, a dedicated research organization focused on advancing open-source AI. We believe in a healthy, open frontier model ecosystem. To enable this, we are working on: - Blue-sky research on continual learning, the science of RL, and how models learn across their full lifecycle, with every experiment and recipe shared openly. - The BaseHub Data Foundry: the highest-quality open RL environments, training data, and real-world benchmarks, built for anyone to train and benchmark on. - Post-post training: taking open-source models and making them better, safer, and more aligned through continual post-training, built on our research, and deployed with our frontier safety stack so organizations can use open-source models with confidence. - Making models cheaper and more performant through our model performance research. This is a mission-driven research effort, not a commercial product. We believe the health of the open-source AI ecosystem matters and that the best way to advance it is to do science in the open. We’re hiring engineers, researchers, and research fellows to advance this mission.

Base Labs

243,991 views • 1 month ago

American Surgeon shows the actual letter from UnitedHealthcare DENYING a patient in emergency condition from receiving care “This is a woman who was in the emergency room with pulmonary embolisms” “I think we all knew this would happen. I had another patient come in and share with me that UnitedHealthcare denied her inpatient's day. So this is a patient who had shortness of breath and some chest pain, and she just knew that something wasn't right in her body. She had a family history of blood clots and she'd had a deep flap surgery a couple of weeks ago. She went to the hospital and they saw her and they found that she had a life threatening condition known as pulmonary embolisms. So she was admitted to the hospital and taken care of really well by the doctors there. And they ordered all the right things. After a couple of days, she was discharged. She got a letter from UnitedHealthcare explaining that they didn't agree with the level of her care and that they would not cover it. So I'm gonna share some of the language of that letter with you, and I want you to know that my patient that we talked about previously who had her surgery denied had almost exactly the same letter shared. So there's some troubling things in this letter. I think this term is really interesting. United is saying they reviewed the request for inpatient admission. So let's all just pause and consider that. This is a woman who was in the emergency room with pulmonary embolisms, and the doctor wasn't really requesting anything. They were saying this patient needs to be in the hospital. But an insurance company sees this as a request, and that's part of this prior auth environment that we're living in. So I think it's important as patients and as physicians to just acknowledge that this is our reality now. Someone can think that there's a good medical decision for you and can write orders and wanna do the right thing for you, but your insurance company is seeing that as a request and deciding whether or not they wanna do it. One of the criteria that this insurance company used to decide whether or not to accept or deny this request was whether it's medically necessary. And it's so interesting that we're letting insurance companies and the doctors who work for insurance companies determine what's medically necessary and not just the doctor in front of the patient in the emergency room. So this is a really bold statement from UnitedHealthcare for my patient. They say you did not have to be admitted as an inpatient to the hospital for this care. I think we all need to just reflect on that. An insurance company is telling a patient and her doctor that they disagree with the plan of care to keep that patient safe. I know that this is boiling down to whether it's an inpatient admission or an observation admission, and that's really about money. But what I wanna point out to you is they're making medical decisions. This insurance company is actually weighing in and disagreeing with a doctor who made a medical decision to admit this patient for her safety. So this specific sentence, when a doctor or facility treats a patient above the recommended level of care, we cannot cover it. What the heck? That's what we do. We go above and beyond as physicians. It's clear that insurance companies don't, and they're actually saying it here.”

American Surgeon shows the actual letter from UnitedHealthcare DENYING a patient in emergency condition from receiving care “This is a woman who was in the emergency room with pulmonary embolisms” “I think we all knew this would happen. I had another patient come in and share with me that UnitedHealthcare denied her inpatient's day. So this is a patient who had shortness of breath and some chest pain, and she just knew that something wasn't right in her body. She had a family history of blood clots and she'd had a deep flap surgery a couple of weeks ago. She went to the hospital and they saw her and they found that she had a life threatening condition known as pulmonary embolisms. So she was admitted to the hospital and taken care of really well by the doctors there. And they ordered all the right things. After a couple of days, she was discharged. She got a letter from UnitedHealthcare explaining that they didn't agree with the level of her care and that they would not cover it. So I'm gonna share some of the language of that letter with you, and I want you to know that my patient that we talked about previously who had her surgery denied had almost exactly the same letter shared. So there's some troubling things in this letter. I think this term is really interesting. United is saying they reviewed the request for inpatient admission. So let's all just pause and consider that. This is a woman who was in the emergency room with pulmonary embolisms, and the doctor wasn't really requesting anything. They were saying this patient needs to be in the hospital. But an insurance company sees this as a request, and that's part of this prior auth environment that we're living in. So I think it's important as patients and as physicians to just acknowledge that this is our reality now. Someone can think that there's a good medical decision for you and can write orders and wanna do the right thing for you, but your insurance company is seeing that as a request and deciding whether or not they wanna do it. One of the criteria that this insurance company used to decide whether or not to accept or deny this request was whether it's medically necessary. And it's so interesting that we're letting insurance companies and the doctors who work for insurance companies determine what's medically necessary and not just the doctor in front of the patient in the emergency room. So this is a really bold statement from UnitedHealthcare for my patient. They say you did not have to be admitted as an inpatient to the hospital for this care. I think we all need to just reflect on that. An insurance company is telling a patient and her doctor that they disagree with the plan of care to keep that patient safe. I know that this is boiling down to whether it's an inpatient admission or an observation admission, and that's really about money. But what I wanna point out to you is they're making medical decisions. This insurance company is actually weighing in and disagreeing with a doctor who made a medical decision to admit this patient for her safety. So this specific sentence, when a doctor or facility treats a patient above the recommended level of care, we cannot cover it. What the heck? That's what we do. We go above and beyond as physicians. It's clear that insurance companies don't, and they're actually saying it here.”

Wall Street Apes

115,739 views • 1 year ago

The health care debate comes down to a simple choice: Do we continue subsidizing big insurance companies? Or do we empower patients to make smart health care choices and put more money in their pockets? It’s not a hard decision. I choose the patient 100% of the time.

The health care debate comes down to a simple choice: Do we continue subsidizing big insurance companies? Or do we empower patients to make smart health care choices and put more money in their pockets? It’s not a hard decision. I choose the patient 100% of the time.

U.S. Senator Bill Cassidy, M.D.

84,446 views • 10 months ago

Dr. Caleb Masterson say health insurance companies are openly breaking laws in Alabama He explains some of his patients situations with insurance companies - “I had an insurance company tell a patient that no authorization for the procedure was required, the procedure was performed, and then the patient was denied the care because the procedure was never authorized. So the patient got charged the entire cost of the procedure” - “I had another patient who is supposed to be due an answer to an insurance claim within 30 days of submission. If they do not reply within 30 days, that's breaking Alabama law. And that claim is currently at the 65th day, so its insurance can be breaking the law.” - “Then I had an insurance company deny care to a patient that they had previously approved. So a patient qualified for surgery based on medical necessity, they had met all the criteria for surgery, they underwent surgery, then the patient had that surgery denied. The patient submitted that information to the insurance company and said, Hey, look, this was already pre-approved. And they said, We reversed our decision and the patient had to pay.”

Dr. Caleb Masterson say health insurance companies are openly breaking laws in Alabama He explains some of his patients situations with insurance companies - “I had an insurance company tell a patient that no authorization for the procedure was required, the procedure was performed, and then the patient was denied the care because the procedure was never authorized. So the patient got charged the entire cost of the procedure” - “I had another patient who is supposed to be due an answer to an insurance claim within 30 days of submission. If they do not reply within 30 days, that's breaking Alabama law. And that claim is currently at the 65th day, so its insurance can be breaking the law.” - “Then I had an insurance company deny care to a patient that they had previously approved. So a patient qualified for surgery based on medical necessity, they had met all the criteria for surgery, they underwent surgery, then the patient had that surgery denied. The patient submitted that information to the insurance company and said, Hey, look, this was already pre-approved. And they said, We reversed our decision and the patient had to pay.”

Wall Street Apes

46,070 views • 8 months ago

Members of the Jehovah’s Witnesses often carry advance directive cards (ID Cards) stating their refusal of blood transfusions in medical emergencies. As doctors, we have an ethical duty to explain when a transfusion is medically necessary and outline the risks. However, once a competent patient makes an informed decision, we must respect their wishes, even when it is difficult. Situations like the one portrayed in Grey’s Anatomy are more common in real clinical practice than many people realize.

Members of the Jehovah’s Witnesses often carry advance directive cards (ID Cards) stating their refusal of blood transfusions in medical emergencies. As doctors, we have an ethical duty to explain when a transfusion is medically necessary and outline the risks. However, once a competent patient makes an informed decision, we must respect their wishes, even when it is difficult. Situations like the one portrayed in Grey’s Anatomy are more common in real clinical practice than many people realize.

SportsDokitor (Odogwu👆)

60,539 views • 7 months ago

What if AI could help doctors recognize when a patient is beginning to deteriorate? At the third annual TIME100 AI Impact Dinner in San Francisco, Suchi Saria, founder of Bayesian Health, shared the personal story behind her work. In 2017, Saria lost her nephew to sepsis. She had already spent years studying whether routinely collected clinical data could reveal when patients were beginning to deteriorate, but when her own family needed that science, she realized it had not yet become a system that could be used in care. Today, Bayesian Health’s system analyzes clinical notes, lab results, clinical history and vital signs for shifts that suggest a patient may be at risk for an adverse medical event. Read more about Suchi Saria’s mission here:

What if AI could help doctors recognize when a patient is beginning to deteriorate? At the third annual TIME100 AI Impact Dinner in San Francisco, Suchi Saria, founder of Bayesian Health, shared the personal story behind her work. In 2017, Saria lost her nephew to sepsis. She had already spent years studying whether routinely collected clinical data could reveal when patients were beginning to deteriorate, but when her own family needed that science, she realized it had not yet become a system that could be used in care. Today, Bayesian Health’s system analyzes clinical notes, lab results, clinical history and vital signs for shifts that suggest a patient may be at risk for an adverse medical event. Read more about Suchi Saria’s mission here:

TIME

47,554 views • 25 days ago

Send the patient home. Wait until their lips turn blue. Bring them in, put them in a coma, put them on a ventilator, and watch nine out of ten of them die. That was the official protocol, set by the WHO, the UN, and the United States government. Meanwhile, the doctors who refused to follow it, the ones who kept the Hippocratic Oath and treated the patient in front of them with whatever actually worked, were getting twice the survival rate. And those are the doctors who lost their licenses. Every single one of them, shut down, for having the best outcomes in the world and refusing to stay quiet about it. What we're left with is a medical establishment that purged its best doctors to protect a protocol that was killing nine out of ten people who followed it. That isn't a mistake. That is the greatest medical fraud that has ever taken place.

Send the patient home. Wait until their lips turn blue. Bring them in, put them in a coma, put them on a ventilator, and watch nine out of ten of them die. That was the official protocol, set by the WHO, the UN, and the United States government. Meanwhile, the doctors who refused to follow it, the ones who kept the Hippocratic Oath and treated the patient in front of them with whatever actually worked, were getting twice the survival rate. And those are the doctors who lost their licenses. Every single one of them, shut down, for having the best outcomes in the world and refusing to stay quiet about it. What we're left with is a medical establishment that purged its best doctors to protect a protocol that was killing nine out of ten people who followed it. That isn't a mistake. That is the greatest medical fraud that has ever taken place.

Del Bigtree

147,510 views • 17 days ago

In our prospective clinical study, our models were able to pinpoint the gestational age within 4 days of accuracy which is a tight enough zone that can have a really meaningful clinical impact. If we're able to expand these tools to low resource settings, we can start to move the needle on maternal deaths and bridge that gap in care that we see all over the world.

In our prospective clinical study, our models were able to pinpoint the gestational age within 4 days of accuracy which is a tight enough zone that can have a really meaningful clinical impact. If we're able to expand these tools to low resource settings, we can start to move the needle on maternal deaths and bridge that gap in care that we see all over the world.

Google

23,569 views • 3 days ago